Novo Nordisk Faces $70M Sales Rep OT Action

Law360, New York (March 5, 2012, 1:50 PM EST) -- A subsidiary of Danish pharmaceutical giant Novo Nordisk A/S was slapped with a $70 million putative class and collective action in New York federal court Monday, which accuses the company of misclassifying its sales representatives as exempt from overtime pay requirements.

Two sales representatives — one current, one former — filed a complaint against Novo Nordisk Inc. that asked for more than $50 million in unpaid wages and liquidated damages under the federal Fair Labor Standards Act, and more than $20 million for violating the New...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.